Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1993-03-08
1997-09-09
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514529, 514547, 514548, 546335, 549 76, 549496, 560 41, 560125, 560171, C07C22936, C07C22924
Patent
active
056657749
ABSTRACT:
This invention relates to a novel class of immunosuppressive compounds having an affinity for the FK-506 binding protein (FKBP). Once bound to this protein, the immunosuppressive compounds inhibit the prolyl peptidyl cis-trans isomerase (rotamase) activity of the FKBP and inhibit T cell activation. As such, the compounds of this invention can be used as immunosuppressive drugs to prevent or significantly reduce graft rejection in bone marrow and organ transplantations and for use in the treatment of a wide variety of autoimmune diseases in humans and other mammals.
REFERENCES:
patent: 3646061 (1972-02-01), Maeda et al.
patent: 5204338 (1993-04-01), Baader et al.
Caufield, C.R. and J.H. Musser, "Macrocyclic Immunomodulators", Annual Reports in Medicinal Chemistry, Johns (Ed.), Academic Press, Inc., 21:195-204 (1989).
Egbertson et al., "Synthetic Route to the `tricarbonyl `Region of FK-506", J. Org. Chem., 54:11-12 (1989).
Coleman et al.,"Degradation and Manipulations of the Immunosuppressant FK506: Preparation of Potential Synthetic Intermediates", Heterocycles 28:157-61 (1989).
Finberg et al., "Prevention of HIV-1 Infection and Preservation of CD4 Function by the Binding of CPFs to gp1120", Science, 249:287-291 (Jul. 20, 1990).
Kaczmar et al., "Darstellung verschiedener Schlangenkafig-Polyektrolyte auf der Basis von Polyacrylamiden und einem Anionenaustauscher", Makromol. Chem. 177:1981-9 (1976).
Blaschke et al., "Investigation of Chromatographic Resolutions of Racemates, VI", Chemical Abstracts, 85:78405k (1976).
Effenberger et al., "Amino Acids", Chemical Abstracts, 110:154847h (1989).
Soai, K., and M. Ishizaki, "Diastereoselective Asymmetric Allylation of Chiral .alpha.Keto-amides with Allyltrimethylsilane. Preparation of Protected Homoallylic Alcohols", J. Chem. Soc. Chem. Commun., 15:1016-17 (1984).
Soai, K. and H. Hasegawa, "Diastereoselective Reduction of Chiral .alpha.-Ketoamides Derived from (S)-Proline Esters with Sodium Borohydride. Preparation of Optically Active .alpha.-Hydroxy Acids", J. Chem. Soc. Perkins Trans., 4:769-772 (1985).
Boulmedais et al., "Stereochimie dela reduction electrochimique d'.alpha.-cetoamides optiquement actives II. Electroreduction de benzoylformamides derives de la S(-)-proline", Bull. Soc. Cim. Fr. 2:185-91 (1989).
Williams et al., "Synthesis of the , -Diketo Amide Segment of the Novel Immunosuppressive FK506", J. Org. Chem. 53:4643-4644 (1988).
Meijeringh, Rec. Destrauax Chimiques Des Pays-Bas et de la Belqique, vol.32, pp. 140-157 (1913).
Maeda et al.II, Bull. Chem. Soc. Japan, vol. 42, pp. 1435-1437 (1969).
Cunliffe et al., J. Med. Chem. vol. 35, pp. 2652-2658, Jul. 1992.
Mulliez et al., Tet., 40(24), pp. 5143-5151 (1984).
Armistead David M.
Boger Joshua S.
Meyers Harold V.
Saunders Jeffrey O.
Tung Roger D.
Dentz Bernard
Haley, Jr. James F.
Marks Andrew S.
LandOfFree
Immunosuppressive compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunosuppressive compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppressive compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-70677